Literature DB >> 3195999

Antagonistic effect of chloramphenicol in combination with cefotaxime or ceftriaxone.

B I Asmar1, M Prainito, A S Dajani.   

Abstract

We evaluated the in vitro interaction at clinically attainable concentrations of cefotaxime and ceftriaxone with chloramphenicol against 26 clinical isolates of gram-negative rods, group B streptococci, and Staphylococcus aureus. Cefotaxime and ceftriaxone were bactericidal against all 26 organisms (MBC, 0.03 to 4 micrograms/ml). Chloramphenicol was bacteriostatic against 24 organisms (MBC, greater than or equal to 32 micrograms/ml) and bactericidal against two Escherichia coli isolates (MBC, 8 micrograms/ml). Checkerboard testing showed chloramphenicol to be antagonistic to the bactericidal activity of cefotaxime and ceftriaxone for all 24 bacteria for which chloramphenicol was bacteriostatic. Time kill curves for selected strains of E. coli and group B streptococci for which chloramphenicol was bacteriostatic showed antagonism of chloramphenicol to both cephalosporins. The combination of chloramphenicol with either cephalosporin was antagonistic in cases in which chloramphenicol was bacteriostatic against the above organisms and should be avoided in the treatment of infections caused by such organisms if bactericidal therapy is desired.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3195999      PMCID: PMC175871          DOI: 10.1128/AAC.32.9.1375

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites.

Authors:  G B ELION; S SINGER; G H HITCHINGS
Journal:  J Biol Chem       Date:  1954-06       Impact factor: 5.157

2.  Studies on antibiotic synergism and antagonism; the interference of chloramphenicol with the action of penicillin.

Authors:  E JAWETZ; J B GUNNISON; R S SPECK; V R COLEMAN
Journal:  AMA Arch Intern Med       Date:  1951-03

3.  Factors influencing the therapy of experimental Proteus mirabilis meningitis in rabbits.

Authors:  L J Strausbaugh; M A Sande
Journal:  J Infect Dis       Date:  1978-03       Impact factor: 5.226

4.  Studies on the pathogenesis of meningitis. VI. Antagonism between penicillin and chloramphenicol in experimental pneumococcal meningitis.

Authors:  J F Wallace; R H Smith; M Garcia; R G Petersdorf
Journal:  J Lab Clin Med       Date:  1967-09

5.  Antagonism by chloramphenicol of broad-spectrum beta-lactam antibiotics against Klebsiella pneumoniae.

Authors:  T H Brown; R H Alford
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

6.  Ampicillin-chloramphenicol interaction against enteric Gram-negative organisms.

Authors:  B I Asmar; A S Dajani
Journal:  Pediatr Infect Dis       Date:  1983 Jan-Feb

7.  Antagonism of ampicillin and chloramphenicol for meningeal isolates of group B streptococci.

Authors:  J L Weeks; E O Mason; C J Baker
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

  7 in total
  2 in total

1.  Evaluating aztreonam and ceftazidime pharmacodynamics with Escherichia coli in combination with daptomycin, linezolid, or vancomycin in an in vitro pharmacodynamic model.

Authors:  Kerry L LaPlante; George Sakoulas
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

2.  In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates.

Authors:  Christoph Hauser; Lea Hirzberger; Magnus Unemo; Hansjakob Furrer; Andrea Endimiani
Journal:  Antimicrob Agents Chemother       Date:  2014-12-29       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.